← Back to Search

Neurotoxin

AbobotulinumtoxinA 300 UNT for Plantar Fibroma

Phase 2
Waitlist Available
Led By Babak Baravarian, DPM
Research Sponsored by University Foot and Ankle Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 26 weeks
Awards & highlights

Study Summary

This study is evaluating whether a botulinum toxin injection into the calf muscle may help improve flexibility and reduce pain for individuals with plantar fasciitis.

Eligible Conditions
  • Plantar Fibroma
  • Plantar Fasciitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~26 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 26 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
injection
Secondary outcome measures
AOFAS Ankle-Hindfoot Score
Adverse Events
FAAM Foot and Ankle Ability Measure
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single groupExperimental Treatment1 Intervention
Single group
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Botulinum toxin type A
FDA approved

Find a Location

Who is running the clinical trial?

University Foot and Ankle FoundationLead Sponsor
1 Previous Clinical Trials
33 Total Patients Enrolled
Babak Baravarian, DPMPrincipal InvestigatorUniversity Foot & Ankle Foundation
1 Previous Clinical Trials

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
University Foot & Ankle Institute
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Evaluating the Safety and Effect of abobotulinumtoxinA in the Gastrocnemius Muscle to Improve Equinus and Plantar Fasciitis Pain
Maha K. Curley 2019. "Evaluating the Safety and Effect of abobotulinumtoxinA in the Gastrocnemius Muscle to Improve Equinus and Plantar Fasciitis Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03978234.
All > Plantar Fasciitis
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top